Vye Ventures

What Vye Ventures does

Vye Ventures is a founder-led, private venture capital syndicate established in 2021 and based in Scottsdale, Arizona. Founded and led by Bradley Mullen, M.D., the firm makes pre-seed and seed stage equity investments in early-stage companies across four sectors: biotech, medical devices, health-tech/healthcare, and hardtech/deeptech/hardware unrelated to biosciences. More than 90% of its activity is concentrated at the pre-seed and seed stages, targeting companies pursuing "0 to 1" scientific innovation (new molecules, devices, or processes), healthcare-focused SaaS/AI/ML and networking solutions, and large-TAM opportunities with a stated objective of 30–100x or greater venture-scale returns.

The firm operates not as a technology company but as an investment vehicle structured as a syndicate on the AngelList platform, which provides the underlying infrastructure for investor accreditation, deal management, and fund administration. This allows accredited limited partners to co-invest alongside Vye Ventures in individual deals. Reported scale metrics include a typical investment of approximately $81,000 per deal, roughly 5 expected deals per year, a dealflow of approximately 0–2 high-quality deals per month, and 73 unique LPs who have invested through the syndicate. Its disclosed portfolio comprises nine visible companies: Bolt Graphics, Lutroo Imaging, Melio, CuraFi, Henry Meds, Keyo, The Complete Human Co., MD.ai, and Enter.health.

The business model generates returns through equity stakes in early-stage startups, realized via portfolio company exits through IPO or acquisition, with a stated commitment to distribute shares to LPs at the earliest possible date following an exit rather than holding to optimize toward a target price. Differentiation rests primarily on the founder's medical expertise, which is positioned as a source of due-diligence conviction and advisory value for healthcare and biotech investments, supported by testimonials from portfolio founders (Enter.health, Lutroo Imaging, MD.AI) and a co-investor (Zach Coelius of Coelius Capital).

Name

Vye Ventures

Legal name

Vye Ventures

Website

https://vye.vc

Company type

Private

Founded year

2021

Operating status

Operating

Headcount range

1–10 employees

Short description

Vye Ventures is a founder-led venture capital syndicate on AngelList, making pre-seed and seed stage investments in biotech, medical device, health-tech, and hardtech/deeptech startups, enabling accredited LPs to co-invest alongside founder Bradley Mullen, M.D.

Ownership category

akta.pro rank

Product category

Venture Capital Investing

NAICS

Other Investment Pools and Funds (5259), Miscellaneous Financial Investment Activities (523999)

SIC

Investment Advice (6282)

akta.pro primary industry

Early-Stage Venture Capital (Pre-Seed/Seed) (FSANAAAA)

akta.pro secondary industries

Micro-VC & Angel Funds (FSANAAAI), Sector-Focused Venture Capital (Vertical Specialists) (FSANAAAD)

Keywords

• Venture capital investing
• Seed stage funding
• Biotech investments
• Medical device funding
• Health-tech venture capital

Headquarters

HQ city

Scottsdale

HQ country

United States

HQ region

North America

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales

Revenue model

1. Venture Capital Returns: Generates returns through equity investments in early-stage startups. Revenue realized through portfolio company exits via IPO or acquisitions. The firm distributes shares to LPs at earliest possible date following exit events.

Pricing tiers

Go-to-market motion1 record

Distribution channels1 record

Marketing channels1 record

Core offering

Vye Ventures is a mission-driven venture capital syndicate that invests in pre-seed and seed stage companies (over 90% of activity) in biotech, medical device, health-tech/healthcare, and hardtech/deeptech sectors unrelated to biosciences. Typical investment size is approximately $81k per deal, with 5 expected deals per year and dealflow of roughly 0–2 high quality deals per month. The syndicate operates on AngelList, enabling accredited LPs to co-invest alongside Vye Ventures in deals targeting true scientific innovation, healthcare SaaS/AI/ML solutions, and large TAM opportunities with 30–100x return potential.

Product overview

Vye Ventures is a mission-driven venture capital syndicate focused on improving the human condition through investments in novel companies with driven founders. The firm operates as a single investment syndicate rather than a platform with separate products. Their portfolio includes pre-seed and seed stage investments across four primary categories: Biotech, Medical Device, Health-tech/healthcare, and Hardtech/deeptech/hardware. They invest in companies with true scientific innovation, healthcare-focused SAAS/AI/ML solutions, and large TAM opportunities with potential for 30-100x returns. Their portfolio companies (e.g., Bolt Graphics, Lutroo Imaging, Melio, CuraFi, Henry Meds, Keyo, The Complete Human Co., MD.ai) represent their investment holdings rather than products or services they offer.

Differentiator

Problem solved

Functional benefit

Products and services

• Vye Ventures AngelList Syndicate A mission-driven investment syndicate offering accredited individual LPs the ability to co-invest alongside Vye Ventures in pre-seed and seed stage companies in biotech, medical device, health-tech, and hardtech/deeptech, with a typical investment size of $81k per deal and 5 expected deals per year.

Named customers3 records

Segments3 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

One partnership is on record.

• AngelListcoreGTM or Marketing PartnerAngelList provides the syndicate platform infrastructure enabling Vye Ventures to offer co-investment opportunities to LP investors. The platform handles investor accreditation, deal management, and fund administration for the syndicate.

Scale indicators3 records

Recent moves5 records

Expansion highlights3 records

Broad incumbents

• Khosla Ventures: Large venture firm with material healthcare, biotech, and deeptech allocations across multiple stages. Comparable in healthcare/biotech sector focus and appetite for science-heavy bets, though operates at much larger fund and check sizes.
• ARCH Venture Partners: Large, established biotech-focused VC investing in early-stage life sciences companies. Comparable in biotech thesis and willingness to back novel science, but with multi-billion-dollar funds and Series A/B+ stage.
• Andreessen Horowitz Bio: Biotech-focused fund within Andreessen Horowitz targeting biology as a tech substrate. Comparable in healthcare/biotech thesis and appetite for '0 to 1' biology bets, but at much larger scale and later stages.

Direct peers

• Pioneer Fund: Pre-seed and seed-stage venture fund operating as an AngelList syndicate with a similarly small team structure. Comparable in check size, stage focus, and AngelList-native distribution model.
• Alliance of Angels: One of the largest angel investor networks in the U.S., focused on early-stage startups. Comparable in pre-seed/seed stage and accredited-investor pool structure, though operates as a network rather than a fund.
• Hustle Fund: Pre-seed micro-VC investing in software-heavy startups with small average check sizes and a community-driven LP base. Comparable in fund stage, check size range, and founder-led operating model.
• Boost VC: Pre-seed and seed VC with an explicit deeptech/hardtech thesis alongside software. Comparable in stage focus, deeptech sector overlap, and small-team syndicate/accelerator structure.
• 1517 Fund: Micro-VC backed by Peter Thiel that invests at the earliest stages in young founders, often non-traditional. Comparable in small-check pre-seed model and founder-led syndicate structure.
• BioGenerator: Early-stage investor exclusively focused on biotech and life sciences startups in the St. Louis region. Comparable in healthcare/biotech vertical focus and pre-seed/seed stage emphasis.

Emerging players

• Springboard Enterprises: Accelerator/venture network focused on women-led healthtech and biotech startups. Comparable in healthcare sector focus and early-stage company support, though structured as an accelerator/ecosystem rather than a fund.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat3 records

Key risks6 records

Key highlights6 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments9 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Vye Ventures